$15.48 -0.43 (-2.70%)
11/27/2009 1:00 PM

Phase Forward, Inc. (PFWD)

CAPS Rating: 2 out of 5

A provider of integrated enterprise-level software products, services and hosted solutions for use in its customers' global clinical trial and drug safety monitoring activities.

Featured Broker Partners